diabetic foot ulcer - Nursing Case Study
Pathophysiology
• Primary mechanism: Peripheral neuropathy leads to loss of protective sensation in the feet, making patients unaware of injuries or pressure points that can develop into ulcers.
• Secondary mechanism: Peripheral vascular disease impairs blood flow, reducing oxygen and nutrient supply, and hindering the healing process of any existing wounds.
• Key complication: Infection risk increases due to the impaired immune response in diabetes and the presence of open wounds, potentially leading to severe systemic complications if not managed promptly.
Patient Profile
Demographics:
56-year-old male, construction worker
History:
• Type 2 diabetes diagnosed 10 years ago, hypertension, and hyperlipidemia
• Metformin, Lisinopril, Atorvastatin, and insulin
• No known drug allergies
Current Presentation:
• Chief complaint: Non-healing ulcer on the right foot for 3 weeks
• Key symptoms: Foot pain, swelling, and redness around the ulcer, occasional fever
• Vital signs: Blood pressure 150/95 mmHg, heart rate 92 bpm, respiratory rate 20 breaths per minute, temperature 100.4°F, blood glucose level 210 mg/dL
Section 1
New Diagnostic Results:
Following the initial assessment, the healthcare team ordered a series of diagnostic tests to further evaluate the condition of the ulcer and the overall status of the patient's health. The wound culture results revealed the presence of Staphylococcus aureus, indicating a bacterial infection. Additionally, laboratory tests showed elevated white blood cell count at 14,000/mm³, suggesting a systemic inflammatory response. An X-ray of the right foot was conducted to rule out osteomyelitis, and the results showed no signs of bone involvement, which was a positive finding at this stage.
The patient's hemoglobin A1c level was measured at 9.2%, indicating poor glycemic control over the past few months. This finding aligns with the elevated blood glucose level noted upon presentation and highlights the need for tighter diabetes management. The Doppler ultrasound of the lower extremities confirmed reduced blood flow to the right foot, consistent with peripheral vascular disease, which is significantly contributing to the impaired wound healing.
These diagnostic results underscore the complexity of the patient's condition, emphasizing the need for a multifaceted approach to care. The infection must be addressed promptly with appropriate antibiotics, while strategies to improve blood glucose control and enhance peripheral circulation are critical to prevent further complications. This scenario provides an opportunity for clinical reasoning to prioritize interventions, anticipate potential challenges in management, and plan for ongoing monitoring and evaluation of the patient's response to the treatment regimen.
Section 2
Change in Patient Status:
Over the next 48 hours, the patient's clinical status began to show subtle but significant changes, necessitating close monitoring and further clinical reasoning. The patient's vital signs indicated a slight increase in temperature, now measuring 100.4°F, suggesting a potential exacerbation of the infection. The heart rate rose to 102 beats per minute, and blood pressure remained stable at 135/85 mmHg. Despite the initiation of broad-spectrum antibiotics, the erythema surrounding the ulcer had expanded by approximately 1 cm, and the wound drainage appeared more purulent, with a faint odor, indicating that the infection might not be fully controlled. This raises concerns about the adequacy of the current antimicrobial therapy and prompts consideration of potential antibiotic resistance or the presence of additional pathogens not detected in the initial culture.
Laboratory data provided further insights into the patient's evolving condition. The white blood cell count increased to 16,500/mm³, reinforcing the suspicion of a systemic inflammatory response. Serum markers of inflammation, such as C-reactive protein, were elevated at 45 mg/L, further corroborating the presence of ongoing inflammation. Meanwhile, the patient's fasting blood glucose levels remained elevated, with readings fluctuating between 250-280 mg/dL, indicating persistent hyperglycemia despite adjustments to the insulin regimen. This scenario highlights the interplay between infection, inflammation, and hyperglycemia, complicating the healing process.
Given the current status, the healthcare team must revisit the treatment strategy, considering potential modifications to the antibiotic regimen and exploring options to improve glycemic control. The possibility of an infectious disease consultation to guide antibiotic selection may be warranted, along with a review of the patient's diabetes management plan to ensure optimal insulin dosing and dietary adherence. Addressing these interrelated issues is crucial to prevent further deterioration and promote healing, with continuous assessment and adjustment of the treatment plan based on the patient's dynamic response.
Section 3
New Diagnostic Results:
In light of the patient’s changing status, the healthcare team pursued additional diagnostic evaluations to gain a clearer understanding of the underlying issues contributing to the inadequate response to treatment. A repeat wound culture was obtained, and preliminary results indicated the presence of a mixed infection. In addition to the originally identified gram-positive cocci, the culture revealed the presence of a gram-negative organism, Pseudomonas aeruginosa, which was not covered by the initial antibiotic regimen. This finding necessitated an immediate adjustment to the antibiotic strategy, incorporating an anti-pseudomonal agent to target this resistant pathogen more effectively.
Additionally, imaging studies, including an X-ray of the affected foot, were conducted to assess for any osseous involvement or signs of osteomyelitis. The radiographs showed subtle periosteal elevation and cortical irregularities suggestive of early-stage osteomyelitis. These findings underscored the need for a more aggressive and comprehensive treatment approach, potentially involving consultation with orthopedic specialists and consideration of advanced imaging modalities like MRI for further evaluation.
These diagnostic revelations significantly impacted the patient's care plan, prompting a multidisciplinary approach. The infectious disease team was engaged to provide expertise on tailored antibiotic therapy, while endocrine specialists were consulted to optimize glycemic control strategies. The integration of these findings into the patient's care plan highlighted the complex interplay between infection control and metabolic management, emphasizing the necessity for ongoing vigilance and adaptive clinical strategy to prevent further complications and promote effective healing.
Section 4
Change in Patient Status:
Following the adjustment in the antibiotic regimen to address the mixed infection, the patient initially showed promising signs of improvement. The wound, previously showing signs of stagnation, began to exhibit granulation tissue, and the surrounding erythema showed a slight reduction. However, within a week, the patient's condition took a concerning turn. The patient developed a low-grade fever of 100.4°F, and the wound drainage increased in both volume and purulence. Additionally, the patient reported increased pain in the affected foot, despite adherence to the pain management plan, raising suspicions of further complications.
Lab results revealed a white blood cell count elevation to 15,000/mm³, indicating a systemic inflammatory response. An increase in serum C-reactive protein and erythrocyte sedimentation rate corroborated the inflammatory process. Blood glucose levels, despite the endocrinology team's intensified management, remained erratic, with fasting levels fluctuating between 180-250 mg/dL, further complicating the patient's recovery trajectory. The patient's HbA1c was measured at 9.2%, underscoring the challenge in achieving adequate glycemic control, which is crucial for wound healing and infection resolution.
The care team, concerned about the potential for sepsis and further osteomyelitis progression, escalated the case to the orthopedic and infectious disease specialists. The decision was made to obtain an MRI to better assess the extent of bone involvement and guide the ongoing treatment strategy. In parallel, the patient was started on a more aggressive insulin protocol, and the wound care team initiated advanced therapies, including negative pressure wound therapy, to promote healing. These efforts highlighted the critical need for a coordinated, dynamic approach to managing complex diabetic foot complications, aiming to stabilize the patient's condition and prevent further deterioration.
Section 5
New Diagnostic Results:
Following the decision to perform an MRI, the results revealed alarming findings consistent with osteomyelitis in the metatarsal bones of the affected foot. The imaging showed significant bone marrow edema and cortical erosion, indicating that the infection had indeed spread to the bone. This confirmed the care team's suspicions and necessitated a more aggressive approach to prevent further complications. The orthopedic consultant recommended surgical intervention to debride the necrotic bone tissue, aiming to eradicate the source of infection and improve the overall prognosis.
Accompanying the MRI findings, additional blood cultures were taken and revealed the presence of methicillin-resistant Staphylococcus aureus (MRSA), guiding a refinement in the antibiotic regimen. Vancomycin was introduced to specifically target this resistant strain, with careful monitoring of blood levels to ensure therapeutic efficacy. Concurrently, the patient's renal function was closely monitored due to the nephrotoxic potential of the new antibiotic, with serum creatinine levels checked regularly.
The interdisciplinary team convened to reassess the patient's treatment plan, emphasizing the importance of maintaining strict glycemic control to optimize immune function and wound healing. The endocrinology team adjusted the insulin protocol further, implementing a continuous subcutaneous insulin infusion to stabilize the patient's blood glucose levels more effectively. This comprehensive approach, combining surgical, pharmacological, and glycemic management, highlighted the complexity of treating diabetic foot ulcers with osteomyelitis and underscored the necessity for ongoing vigilance and coordinated care.